SCHEMBL18249751

SCHEMBL18249751

CS(=O)(=O)Nc1ccc(Oc2cc(Cl)nc(Cl)n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.54
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
KIF11 P52732 2/20 0.45
RAB9A P51151 3/20 0.44
LMNA P02545 3/20 0.43
MAPK1 P28482 2/20 0.43
GAA P10253 1/20 0.43
NPC1 O15118 2/20 0.42
SCN9A Q15858 1/20 0.41
HPGD P15428 2/20 0.41
AR P10275 1/20 0.41
MMP2 P08253 2/20 0.41
MMP3 P08254 1/20 0.41
MMP9 P14780 1/20 0.41
MMP14 P50281 1/20 0.41
LTA4H P09960 1/20 0.41
MMP1 P03956 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20239278 0.81 PGR (0.47) PGRMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL20239233 0.79 ALDH1A1 (0.53) MEN1KMT2AALDH1A1SMN1; SMN2RAB9A
SCHEMBL4205144 0.77 PGR (0.85) PGRALDH1A1SMN1; SMN2KIF11RAB9A
SCHEMBL18153300 0.74 MEN1 (0.51) MEN1KMT2AALDH1A1SMN1; SMN2RAB9A
SCHEMBL18951960 0.74 MEN1 (0.50) MEN1KMT2AALDH1A1SMN1; SMN2RAB9A
SCHEMBL18249752 0.72 SMN1; SMN2 (0.51) PGRMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL20239209 0.72 PGR (0.49) PGRMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL24173888 0.71 KIF11 (0.47) ALDH1A1SMN1; SMN2KIF11RAB9ALMNA
SCHEMBL28431150 0.71 MEN1 (0.47) MEN1KMT2AALDH1A1SMN1; SMN2RAB9A
SCHEMBL3116450 0.71 PGR (0.73) PGRMEN1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3298001-B1 DGAT2 INHIBITORS LILLY CO ELI (US) 2020-05-13 EP disclosed
EP-3298001-A1 NOVEL DGAT2 INHIBITORS Eli Lilly and Company (US) 2018-03-28 EP disclosed
WO-2016187384-A1 NOVEL DGAT2 INHIBITORS ELI LILLY AND COMPANY (US) 2016-11-24 WO disclosed